Literature DB >> 26123136

TAVI in 2015: who, where and how?

Neil Ruparelia1, Bernard D Prendergast2.   

Abstract

Mesh:

Year:  2015        PMID: 26123136     DOI: 10.1136/heartjnl-2014-307008

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Comparison of PCWP and LVEDP Measurements in Patients with Severe Aortic Stenosis Undergoing TAVI-Same Same but Different?

Authors:  Elke Boxhammer; Moritz Mirna; Laura Bäz; Brunilda Alushi; Marcus Franz; Daniel Kretzschmar; Uta C Hoppe; Alexander Lauten; Michael Lichtenauer
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

Review 2.  Current controversies in infective endocarditis.

Authors:  Thomas J Cahill; Bernard D Prendergast
Journal:  F1000Res       Date:  2015-11-18

3.  Oxidation-Reduction Potential in Patients undergoing Transcatheter or Surgical Aortic Valve Replacement.

Authors:  Kathrin Heldmaier; Christian Stoppe; Andreas Goetzenich; Ann-Christina Foldenauer; Rachat Zayat; Thomas Breuer; Gereon Schälte
Journal:  Biomed Res Int       Date:  2018-11-14       Impact factor: 3.411

Review 4.  Transcatheter Aortic Valve Replacement: a Kidney's Perspective.

Authors:  Wisit Cheungpasitporn; Charat Thongprayoon; Kianoush Kashani
Journal:  J Renal Inj Prev       Date:  2016-01-18

5.  Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

Authors:  Elke Boxhammer; Moritz Mirna; Laura Bäz; Nina Bacher; Albert Topf; Brigitte Sipos; Marcus Franz; Daniel Kretzschmar; Uta C Hoppe; Alexander Lauten; Michael Lichtenauer
Journal:  Life (Basel)       Date:  2022-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.